Dr. Saber is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9200 W Wisconsin Ave
Milwaukee, WI 53226Phone+1 414-805-0505Fax+1 414-955-0231
Education & Training
- University of Wisconsin Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 2006 - 2009
- Cleveland Clinic FoundationResidency, Internal Medicine, 1998 - 2001
- Ain Shams University Faculty of MedicineClass of 1995
Certifications & Licensure
- WI State Medical License 2006 - 2025
- OH State Medical License 2000 - 2010
- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703.Shernan G Holtan, Javier Bolaños-Meade, Monzr M Al Malki, Juan Wu, Carrie L Kitko
Journal of Clinical Oncology. 2025-03-10 - Donor telomeres and their magnitude of shortening post-allogeneic haematopoietic cell transplant impact survival for patients with early-stage leukaemia or myelodyspla...Shahinaz M Gadalla, Hormuzd A Katki, Tsung-Po Lai, Paul L Auer, Casey L Dagnall
Ebiomedicine. 2025-03-08 - Five-Year Real-World Safety of Inotuzumab Ozogamicin Before Hematopoietic Stem Cell Transplantation in B-Cell Precursor Acute Lymphoblastic Leukemia.Marcos de Lima, Partow Kebriaei, Francesco Lanza, Christina Cho, Gizelle Popradi
American Journal of Hematology. 2025-02-24
Abstracts/Posters
- Allogeneic Hematopoietic Stem Cell Transplantation for Therapy-Related Myelodysplastic Syndromes and Acute Myeloid LeukemiaWael Saber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Myeloablative Conditioning Is Preferred for Allogeneic Transplantation of Acute Myeloid Leukemia and Myelodysplastic Syndromes with Low/Intermediate but Not High Disea...Wael Saber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Superior Survival with Post-Remission Pediatric-Inspired Chemotherapy Compared to Myeloablative Allogeneic Hematopoietic Cell Transplantation in Adolescents and Young ...Wael Saber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Stem Cell Transplant in Patients with Myelodysplastic Syndromes: On Behalf of the CIBMTR Ch...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Lost to Follow-up Rates Are Higher in Pediatric Than Adult Survivors, but Not By Transplant Type: A Report from the Center for International Blood and Marrow Transplan...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- Center for International Blood & Marrow Transplant Research Celebrates 50 YearsApril 22nd, 2022
- Genetic Profiling Can Guide Stem Cell Transplantation for Patients with Myelodysplastic Syndrome, Study FindsFebruary 9th, 2017
- Genetic Profiling Can Guide Stem Cell Transplantation for Patients with Myelodysplastic Syndrome, Study FindsFebruary 8th, 2017
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: